PD-L1 immunohistochemical (IHC) expression could occur more frequently in high-risk localized or metastatic PC tissues, potentially correlating to more aggressive clinic-pathologic features and outcome despite some limits and controversial results (as described in other parts of our review) [27,35,36,39,43]. This evidence concerns the gene CD274 and pachyonychia congenita.